Advair: Profile Of A Potentially Dangerous Drug By: juddieh | - There was a meeting in July of 2005 held by the FDA that decided to leave Advair off of the market for numerous reasons. Advair os a type of drug that is designed to eliminate wheezing as well as other difficulties that comes with asthma. It helps with shortness of breath as well as chest pain. Advair contains the ingredient salmeterol which can be found in Serevent. There have been several concerns that have come up over the years and the FDA has reported that some individuals have suffered sev ... Tags:law, legal, personal injury, attorney, lawyer, health, drugs, medicine
Advair: Brief Review Of A Potentially Dangerous Drug By: Articlesonline | - There was a meeting in July of 2005 held by the FDA that decided to leave Advair off the market for numerous reasons. Advair is a type of drug that is designed to eliminate wheezing as well as other difficulties that comes with asthma. It helps with shortness of breath as well as chest pain. Advair contains the ingredient salmeterol which can be found in Serevent. There have been several concerns that have come up over the years and the FDA has reported that some individuals have suffered severa ... Tags:law, legal, personal injury, attorney, lawyer, health, drugs
Fluticasone Nasal Sp To Treat Asthmas Symptoms By: Bhupinder Kaur Khera | - Fluticasone nasal spray, a synthetic corticosteroid, treats asthma and allergic rhinitis effectively. It is also used to treat eosinophilic esophagitis. Corticosteroids are strong drugs and usually can control even severe cases of asthma over the long term and maintain good lung function. This medication is also available as a cream for the treatment of eczema and psoriasis.
Fluticasone is marketed under the different names in different countries. For instance Flovent and Flixotide ... Tags:asthmas symptoms, fluticasone nasal sp
Patent Strategies By: GBI Research | - The pharmaceutical industry is going to experience major patent expiries during 2010-2014, of which 2010 to 2012 are expected to be peak years, with the loss of patents for drugs whose sales were more than $60 billion during 2009.
In 2010, major drugs like Lipitor, Cozaar, Advair, Arimidex, Flomax and Gemzar, with combined sales revenues of more than $24 billion, are expected to face generic competition. In 2011, nine drugs of six companies are going to experience a major impact of ... Tags:Patent Strategies, Product Lifecycles, Generics Markets
Drug Markups And The Role Of Supplements By: Pat Boardman | - The gigantic drug industry captitalizes on the consumer's search for security from symptoms. The profit margin is partially due to low-cost ingredients being marked up on a scale that any other industry would envy. Sharon Davis and Mary Palmer, budget analysts for the United States Department of Commerce did an independent study on the costs of the active ingredients in commercial drugs in America relative to the consumer price. They published articles on their findings in several issues of Life ... Tags:leg cramps, rls, legs, insomnia, sleep, treatment, restless leg syndrome, restless legs, remedy
